logo-loader
viewHepQuant LLC

HepQuant CEO sees 'huge, unmet need' in the liver space

HepQuant LLC CEO Greg Everson joined Proactive at the Biotech Showcase 2020 in San Francisco. HepQuant is a privately-held, early-stage medical diagnostics company who's technology, licensed from the University of Colorado Denver, assesses the liver function of patients with chronic liver disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics looking to attack opioid crisis with...

Empower Clinics (CSE:CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling from Proactive in Toronto to discuss the company creating a division focussing on psilocybin and psychedelics aka magic mushrooms. McAuley telling Proactive how key this may become considering the...

4 hours, 23 minutes ago

2 min read